Pharmaceutical

Healthcare BPO Market Anticipates USD 626.6 Billion by 2029 with 9.7% CAGR | MarketsandMarkets™

CHICAGO, June 18, 2024 /PRNewswire/ -- The Healthcare BPO market is projected to grow from USD 395.3 billion in 2024 to USD…

7 months ago

Singleron Biotechnologies partners with the Human Cell Atlas (HCA) to enhance access to single cell analysis globally

COLOGNE, Germany, June 18, 2024 /PRNewswire/ -- Singleron Biotechnologies announced a partnership with the Human Cell Atlas (HCA) to help accelerate…

7 months ago

CO2Meter Launches GasLab® Industrial Fixed Gas Detector Series

CO2Meter launches new Industrial Gas Detector Series featuring up to 128 sensor capabilities ORMOND BEACH, Fla., June 18, 2024 /PRNewswire/…

7 months ago

Axtria Announces its First Ignite Leadership Award Honorees

Award Honors Top Executives Fueling Innovation and Impact in the Life Sciences Industry BERKELEY HEIGHTS, N.J., June 18, 2024 /PRNewswire/ --…

7 months ago

Petauri Adds Mtech Access and Delta Hat in Global Expansion

Rapidly growing pharmaceutical services platform announces transformational expansion, acquiring two leading businesses focused on evidence-based value demonstration and global market…

7 months ago

Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent

CHICAGO, IL / ACCESSWIRE / June 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

7 months ago

Acadia Pharmaceuticals Presents DAYBUE™ (trofinetide) Real-World Evidence and Additional Data in Rett Syndrome at the 2024 International Rett Syndrome Foundation (IRSF) Annual Scientific Meeting

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals, Inc. (Nasdaq: ACAD) today announced that interim data from the open-label real-world LOTUS™ study will be…

7 months ago

Aytu BioPharma Announces Paydown and Refinancing of Term Loan on More Favorable Terms

Company receives proceeds of $3.5 million through exercise of warrants, a portion of which was used to pay down debtInterest…

7 months ago

Rutherrin(R) Increases Efficacy of Immunotherapy Preclinically

TORONTO, ON / ACCESSWIRE / June 18, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage…

7 months ago